stockrowAlcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) EV/FCF
As of 5 November 2026, Alcon (ALC) trades at a EV/FCF of 25.4×. Over the past ten years it has ranged from 20.9× (May 2026) to 642× (April 2022); the current reading is higher than 8% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 26.0× | (18.19%) |
| FY2024 | 31.8× | (58.94%) |
| FY2023 | 77.5× | (2.60%) |
| FY2022 | 79.6× | (70.94%) |
| FY2021 | 274× | 106.06% |
| FY2020 | 133× | 7.13% |
| FY2019 | 124× | 140.30% |
| FY2018 | 51.6× | 0.00% |
| FY2017 | 51.6× | 0.00% |
| FY2016 | 51.6× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 22.5× | (9.60%) |
| Mar 2026 | 24.9× | (4.26%) |
| Dec 2025 | 26.0× | (9.81%) |
| Sep 2025 | 28.9× | (13.18%) |
| 28 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| SOLV Solventum Corporation compare | 0.0× |
| MDLN Medline Inc. compare | 14.5× |
| ALGN Align Technology, Inc. compare | 15.1× |
| BAX Baxter International Inc. compare | 17.5× |
| RMD ResMed Inc. compare | 21.0× |
| COO The Cooper Companies, Inc. compare | 21.6× |
| BDX Becton, Dickinson and Company compare | 22.2× |
| ALC Alcon | 25.4× |
| WST West Pharmaceutical Services, Inc. compare | 61.0× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on ALC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement